MedTrace Logo

Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Thrombectomy on Acute Basilar Artery Occlusion

NCT05827042 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 338

Last updated 2024-10-01

No results posted yet for this study

Summary

To assess the effect of endovascular thrombectomy alone compared to intravenous thrombolysis plus endovascular thrombectomy in acute basilar artery occlusion patients within 4.5 hours from onset on efficacy and safety outcomes.

Conditions

  • Basilar Artery Occlusion
  • Acute Cerebrovascular Accident
  • Stroke Due to Basilar Artery Occlusion

Interventions

DRUG

Intravenous thrombolysis

Patients will receive intravenous alteplase (0.9mg/kg, maximum 90mg) or tenecteplase (0.25mg/kg, maximum 25mg) before endovascular thrombectomy.

PROCEDURE

Endovascular thrombectomy

Endovascular thrombectomy

Sponsors & Collaborators

  • The First Affiliated Hospital of University of Science and Technology of China

    lead OTHER

Principal Investigators

  • Wei Hu, MD · The First Affiliated Hospital of University of Science and Technology of China

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-09
Primary Completion
2025-12-31
Completion
2026-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05827042 on ClinicalTrials.gov